Source: ERJ Open Res, 7 (4) 00411-2021; 10.1183/23120541.00411-2021



Rating:

Share or cite this content

Citations should be made in the following way:
Andreas Jung, Annalisa Orenti, Fiona Dunlevy, Elina Aleksejeva, Egil Bakkeheim, Vladimir Bobrovnichy, Siobhán B. Carr, Carla Colombo, Harriet Corvol, Rebecca Cosgriff, Géraldine Daneau, Deniz Dogru, Pavel Drevinek, Andrea Dugac Vukic, Isabelle Fajac, Alice Fox, Stojka Fustik, Vincent Gulmans, Satenik Harutyunyan, Elpis Hatziagorou, Irena Kasmi, Hana Kayserová, Elena Kondratyeva, Uros? Krivec, Halyna Makukh, Kestutis Malakauskas, Edward F. McKone, Meir Mei-Zahav, Isabelle de Monestrol, Hanne Vebert Olesen, Rita Padoan, Tsitsino Parulava, Maria Dolores Pastor-Vivero, Luísa Pereira, Guergana Petrova, Andreas Pfleger, Liviu Pop, Jacqui G. van Rens, Milan Rodic´, Marc Schlesser, Valérie Storms, Oxana Turcu, Lukasz Woz´niacki, Panayiotis Yiallouros, Anna Zolin, Damian G. Downey, Lutz Naehrlich. Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe. ERJ Open Res, 7 (4) 00411-2021; 10.1183/23120541.00411-2021

Member's Comments

No comment yet.

Related content which might interest you: Factors associated with recurrence of severe exacerbations in Non-cystic fibrosis bronchiectasis in developping countries. Source: International Congress 2019 – Clinical problems Year: 2019 Improved survival albeit with persistent disparities in prognosis for people with cystic fibrosis in European countries Source: Eur Respir J, 58 (3) 2101487; 10.1183/13993003.01487-2021 Year: 2021 Impact of CFTR modulator use on outcomes in people with severe cystic fibrosis lung disease Source: Eur Respir Rev, 29 (155) 190112; 10.1183/16000617.0112-2019 Year: 2020 Lumacaftor/ivacaftor-associated health stabilisation in adults with severe cystic fibrosis Source: ERJ Open Res, 7 (1) 00203-2020; 10.1183/23120541.00203-2020 Year: 2021 Oral health and some risk factors in children with cystic fibrosis Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis Year: 2012 Viral infections trigger exacerbations of cystic fibrosis in adults and children Source: Eur Respir J 2012; 40: 510-512 Year: 2012 Non-cystic fibrosis bronchiectasis: etiology and predictors of exacerbations and mortality in patients across the largest health system in central and western Massachusetts Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies Year: 2017 Early determinants of lung disease in children with cystic fibrosis Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology Year: 2020 Inflammation and infection in infants with cystic fibrosis is associated with changes in lung function in the first year of life Source: Annual Congress 2008 - Respiratory physiology in health and disease Year: 2008 Risk factors for lung disease progression in children with cystic fibrosis Source: Eur Respir J, 52 (4) 1801492; 10.1183/13993003.01492-2018 Year: 2018 Risk factors for lung disease progression in children with cystic fibrosis Source: Eur Respir J, 51 (6) 1702509; 10.1183/13993003.02509-2017 Year: 2018 Factors affecting progression of lung disease among patients with cystic fibrosis Source: International Congress 2019 – Physiology of cystic fibrosis Year: 2019 Predicting five year outcomes in adults with cystic fibrosis: Developing a predictive scoring model Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Incidence and resource utilisation of pulmonary exacerbations in patients with cystic fibrosis in the UK Source: Annual Congress 2010 - New aspects of cystic fibrosis Year: 2010 Cystic fibrosis in South Africa: spectrum of disease and determinants of outcome Source: ERJ Open Res, 7 (3) 00856-2020; 10.1183/23120541.00856-2020 Year: 2021 Predictors of non-cystic fibrosis bronchiectasis in Indigenous adult residents of central Australia: results of a case–control study Source: ERJ Open Res, 5 (4) 00001-2019; 10.1183/23120541.00001-2019 Year: 2019 Audit of management of pseudomonas aeruginosa infection in children with cystic fibrosis Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research Year: 2009 Impact of co-morbidities on disease severity and risk of mortality in non-cystic fibrosis bronchiectasis Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives Year: 2015 The effect of transition from a paediatric to adult cystic fibrosis (CF) centre on clinical status and hospital attendance Source: International Congress 2016 – From pleura to bronchi: new insights Year: 2016 Early deaths in cystic fibrosis: Analysis of causes and risk factors in a pediatric cohort Source: Annual Congress 2012 - Cystic fibrosis (adults and children): risk factors and clinical problems Year: 2012